Thalidomide in refractory and relapsing multiple myeloma

被引：28
|
作者：
Bladé, J [1 ]
Esteve, J [1 ]
Rosiñol, L [1 ]
Perales, M [1 ]
Montoto, S [1 ]
Tuset, M [1 ]
Montserrat, E [1 ]
机构：
[1] Univ Barcelona, Hosp Clin,IDIBAPS, Hematol Dept,Pharm Serv,Inst Invest Biomed August, Inst Hematol & Oncol,Postgrad Sch Hematol Farrera, Barcelona 08036, Spain
来源：
SEMINARS IN ONCOLOGY | 2001年 / 28卷 / 06期
关键词：
D O I：
10.1043/sonc.2001.28610
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：588 / 592
页数：5
相关论文
共 50 条
  • [1] Thalidomide with or without dexamethasone for refractory or relapsing multiple myeloma
    Alexanian, R
    Weber, D
    Anagnostopoulos, A
    Delasalle, K
    Wang, M
    Rankin, K
    SEMINARS IN HEMATOLOGY, 2003, 40 (04) : 3 - 7
  • [2] Thalidomide and dexamethasone combination for refractory multiple myeloma
    Dimopoulos, MA
    Zervas, K
    Kouvatseas, G
    Galani, E
    Grigoraki, V
    Kiamouris, C
    Vervessou, E
    Samantas, E
    Papadimitriou, C
    Economou, O
    Gika, D
    Panayiotidis, P
    Christakis, I
    Anagnostopoulos, N
    ANNALS OF ONCOLOGY, 2001, 12 (07) : 991 - 995
  • [3] Thalidomide for the treatment of relapsed and refractory multiple myeloma
    Cool, RM
    Herrington, JD
    PHARMACOTHERAPY, 2002, 22 (08): : 1019 - 1028
  • [4] Treatment approaches for relapsing and refractory multiple myeloma
    Bladé, J
    Esteve, J
    ACTA ONCOLOGICA, 2000, 39 (07) : 843 - 847
  • [5] A pilot study evaluating thalidomide therapy in relapsing multiple myeloma
    Krivanova, A
    Hajek, R
    Krejci, M
    Adam, Z
    Scudla, V
    Indrak, K
    Bacovsky, J
    Büchler, T
    Svobodnik, A
    Pour, L
    Vostrejsova, S
    Havlikova, K
    Mayer, J
    Vorlicek, J
    BONE MARROW TRANSPLANTATION, 2005, 35 : S49 - S49
  • [6] Thalidomide for resistant and relapsing myeloma
    Alexanian, R
    Weber, D
    SEMINARS IN HEMATOLOGY, 2000, 37 (01) : 22 - 25
  • [7] Antitumor activity of thalidomide in refractory multiple myeloma.
    Singhal, S
    Mehta, J
    Desikan, R
    Ayers, D
    Roberson, P
    Eddlemon, P
    Munshi, N
    Anaissie, E
    Wilson, C
    Dhodapkar, M
    Zeldis, J
    Barlogie, B
    Siegel, D
    Crowley, J
    NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (21): : 1565 - 1571
  • [8] Thalidomide and dexamethasone combination for refractory multiple myeloma.
    Galani, E
    Grigoraki, V
    Kiamouris, C
    Samantas, E
    Economou, O
    Papdimitriou, C
    Gika, D
    Anagnostopoulos, N
    Dimopoulos, M
    ANNALS OF ONCOLOGY, 2000, 11 : 96 - 96
  • [9] Role of thalidomide with or without dexamethasone for refractory multiple myeloma
    Boulin, M
    Blanchet, F
    Isambert, N
    Solary, E
    Solier, S
    Collin, B
    Pernot, C
    Durnet-Archeray, MJ
    THERAPIE, 2002, 57 (06): : 524 - 529
  • [10] Oral melphalan, dexamethasone, and thalidomide for the treatment of refractory multiple myeloma
    Asoua, Norio
    Izuno, Yoshiharu
    Okubo, Toshiya
    Ide, Kazuhiko
    Ueno, Hiroshi
    Kawakita, Makoto
    Hiroaki, Mitsuya
    Hata, Hiroyuki
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2007, 86 (01) : 69 - 71
12345